• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

B. Braun pledges $1B to alleviate IV solution shortages

May 15, 2019 By Fink Densford

B. Braun

B. Braun said yesterday that it is investing $1 billion into new and enhanced IV therapy manufacturing facilities to help alleviate saline and other IV fluid shortages faced by healthcare providers in the U.S.

The investment, dubbed the ‘Solutions for Life’ initiative, includes a new manufacturing facility in Daytona Beach, Fla. and improvements to existing facilities in Irvine, Calif. and Allentown, Penn., Bethlehem, Penn.-based B. Braun said.

“As a family-owned medical device and pharmaceutical company, B. Braun believes in longevity, stability, and partnership. These core values drive our investments to help prevent future U.S. IV fluid shortages and our collaboration in working alongside policymakers, healthcare providers, and supply chain partners to deliver these life-saving fluids. Solutions for Life is our commitment to helping ensure consistent supply of vital saline solutions and other IV fluids that hospitals and health systems depend on to treat patients,” B. Braun CEO & chair Caroll Neubauer said in a press release.

Through the Solutions for Life initiative, B. Braun said that it aims to create additional supply and capacity of critical IV fluids and expand patient access by beefing up supply geographically from a new distribution center in Daytona Beach and improvements to facilities in Ontario, Canada and Breinigsville, Penn.

“As Governor of Florida, I was proud to announce B. Braun’s plan to create a new facility in Daytona Beach, which is expected to bring hundreds of new jobs to the community. I’d like to thank B. Braun for continuing to invest in our state and create opportunities for Florida families, as well as their efforts to provide quality healthcare to Americans,” Senator Rick Scott (R-FL) said in a prepared release.

“IV fluid shortages have the potential to cause serious complications for patients across the country, particularly in times of public health emergencies. B. Braun is making an important investment to address this concern by expanding production capacity and improving the ability to deliver IV fluids when and where they are needed,” Senator Pat Toomey (R-PA) said in prepared remarks.

The company said that it will also look to promote sustainability as the only supplier to offer a full line of IV solution products free from PVC and DEHP and through designing IV fluid bags to be land-fill neutral.

B. Braun added that it has received FDA approval for IV fluids from European facilities, in case needs arise for such a supply in the future.

“The IV fluid shortages in recent years significantly impacted us, especially nurses who experienced the personal heartache of telling patients and their caregivers that fluids were not available. We welcome these investments to expand IV fluid production and, just as important, the opportunity for stakeholders across the healthcare system to come together to explore additional steps to prevent future shortages,” Infusion Nurses Society RN Felicia Schaps said in a prepared statement.

Filed Under: Business/Financial News, Featured, Hospital Care Tagged With: B. Braun Medical

IN CASE YOU MISSED IT

  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor
  • Medtronic to separate Diabetes business unit

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS